<DOC>
	<DOCNO>NCT01340014</DOCNO>
	<brief_summary>The purpose study assess patient preference regard ocular comfort AZARGA® compare COSOPT® one week instillation study medication .</brief_summary>
	<brief_title>Patient Preference Comparison AZARGA Versus COSOPT</brief_title>
	<detailed_description>At Screening Visit , intervention instill one eye contralateral fashion establish baseline ocular comfort prior randomization . A 48-hour washout period separate two treatment period .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<mesh_term>Dorzolamide</mesh_term>
	<mesh_term>Brinzolamide</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Clinical diagnosis ocular hypertension , openangle without pseudoexfoliation pigment dispersion glaucoma eye . On stable regimen intraocular pressurelowering ( IOP ) medication within 30 day Screening Visit . IOP consider safe ( opinion Investigator ) eye way assures clinical stability vision optic nerve throughout study period . IOP 19 35 millimeter mercury ( mmHg ) least one eye ( study eye ) . Willing discontinue use ocular drug ( prescribe overthecounter ) prior receive screen dose Screening Visit entire course study . Able follow instruction willing able attend study visit . Read , sign , date Ethics Committee review approve Informed Consent Form . Other protocoldefined inclusion criterion may apply . Known medical history allergy , hypersensitivity poor tolerance component preparation use study deem clinically significant opinion Principal Investigator . Best correct visual acuity bad 20/80 Snellen either eye . Any abnormality prevent reliable applanation tonometry either eye . Intraocular conventional surgery laser surgery either eye le 3 month prior Screening Visit . Risk visual field visual acuity worsen consequence participation study , Investigator 's best judgment . Progressive retinal optic nerve disease cause . History ocular herpes simplex . Severe allergic rhinitis bronchial hypersensitivity would preclude safe administration topical betablocker . Bronchial asthma , history bronchial asthma , severe chronic obstructive pulmonary disease would preclude safe administration topical betablocker . Women pregnant , lactating , childbearing potential use reliable mean birth control . Participation investigational study within 30 day prior Screening/baseline Visit . Other protocoldefined exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Glaucoma</keyword>
	<keyword>Intraocular pressure</keyword>
	<keyword>Tonometry , ocular</keyword>
</DOC>